Community Collaboration to Advance Racial/Ethnic Equity in Colorectal Cancer Screening: Protocol for a Multilevel Intervention to Improve Screening and Follow-up in Community Health Centers
Folasade P May,Suzanne Brodney,Jessica J Tuan,Sapna Syngal,Andrew T Chan,Beth Glenn,Gina Johnson,Yuchiao Chang,David A Drew,Beverly Moy,Nicolette J Rodriguez,Erica T Warner,Adjoa Anyane-Yeboa,Chinedu Ukaegbu,Anjelica Q Davis,Kimberly Schoolcraft,Susan Regan,Nathan Yoguez,Samantha Kuney,Kelley Le Beaux,Catherine Jeffries,Ellen T Lee,Roopa Bhat,Jennifer S Haas
DOI: https://doi.org/10.1016/j.cct.2024.107639
Abstract:Introduction: Colorectal cancer (CRC) screening utilization is low among low-income, uninsured, and minority populations that receive care in community health centers (CHCs). There is a need for evidence-based interventions to increase screening and follow-up care in these settings. Methods: A multilevel, multi-component pragmatic cluster randomized controlled trial is being conducted at 8 CHCs in two metropolitan areas (Boston and Los Angeles), with two arms: (1) Mailed FIT outreach with text reminders, and (2) Mailed FIT-DNA with patient support. We also include an additional CHC in Rapid City (South Dakota) that follows a parallel protocol for FIT-DNA but is not randomized due to lack of a comparison group. Eligible individuals in participating clinics are primary care patients ages 45-75, at average-risk for CRC, and overdue for CRC screening. Participants with abnormal screening results are offered navigation for follow-up colonoscopy and CRC risk assessment. Results: The primary outcome is the completion rate of CRC screening at 90 days. Secondary outcomes include the screening completion rate at 180 days and the rate of colonoscopy completion within 6 months among participants with an abnormal result. Additional goals are to enhance our understanding of facilitators and barriers to CRC risk assessment in CHC settings. Conclusions: This study assesses the effectiveness of two multilevel interventions to increase screening participation and follow-up after abnormal screening in under-resourced clinical settings, informing future efforts to address CRC disparities. Trial registration: NCT05714644.